Clinical Trials Logo

Clinical Trial Details — Status: Withdrawn

Administrative data

NCT number NCT03555968
Other study ID # 2018502
Secondary ID
Status Withdrawn
Phase Phase 4
First received
Last updated
Start date July 2021
Est. completion date December 2021

Study information

Verified date April 2022
Source Lakehead University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Low blood concentrations of THC and alcohol appear to have a minimal effect on driving performance.However, there is a gap in the literature about the combined effects of THC and alcohol. There is little empirical evidence to determine whether the combination of THC and alcohol could be additive or multiplicative. This issue is particularly important when dealing with concentrations that are just below legal thresholds - it is important to identify if someone who may have consumed cannabis and alcohol, in quantities that do not exceed legal thresholds, may nonetheless be impaired to drive. Answering this question requires more research on the combined effects of THC and alcohol under tightly controlled experimental conditions. Hence, the purpose of this study is to determine the additive (or multiplicative) effect of standardized low doses of cannabis, in combination with low-doses of alcohol, on a number of outcome measures related to driving. The investigators will focus specifically on the effect of low blood concentrations of THC (0, 125, and 250 µg/kg) alone and in combination with low blood concentrations of alcohol (BAC 0%, .025%, and .049%). They shall determine the combined effect of THC and alcohol on physiological, cognitive, subjective measures of impairment, and simulated driving. This study will focus on younger adults because they have higher impaired driving rates than other age groups. As a secondary aim of the study, the investigators will examine whether previous driving and drug use history are correlated with driving decisions during the simulated drive and subjective measures. This study will contribute to the evidence base informing legislation, policy making, and law enforcement. This study is particularly timely given upcoming changes in legislation about cannabis, and because the combination of THC and alcohol, even below legal thresholds, may lead to impaired driving and crashes.


Recruitment information / eligibility

Status Withdrawn
Enrollment 0
Est. completion date December 2021
Est. primary completion date December 2021
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 19 Years to 25 Years
Eligibility Inclusion Criteria: - BMI >18 and <30 - valid G2 or G Ontario driver's license - live on-campus or within 15 minutes drive of campus - speak fluent English Exclusion Criteria: - history of cardiovascular or psychiatric disorders - current use of psychoactive medication - current drug or alcohol abuse problem - positive drug screen - BAC level > .000%

Study Design


Related Conditions & MeSH terms


Intervention

Drug:
THC 0
THC dose = 0mg
THC 5
THC dose = 5mg
THC 10
THC dose = 10mg
Other:
BAC 0
Blood alcohol concentration = .000%
BAC .025
Blood alcohol concentration = .025%
BAC .049
Blood alcohol concentration = .049%

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Lakehead University

Outcome

Type Measure Description Time frame Safety issue
Primary Demerit Points on Simulated Road Test Demerit points incurred for driving errors during a simulated a G2 exit exam (the final step in Ontario's graduated licensing framework) on a STISIM Drive 3-screen driving simulator; demerit points will be assigned in real-time by a member of the research team based on the Ontario Ministry of Transportation scoring scheme @2.5 hours
Secondary Standard Deviation of Lane Position in Meters (STISIM Drive-Recorded Variable) Recorded by the STISIM simulator during the simulation @2.5 hours
Secondary Mean and Standard Deviation of Velocity in Meters/Second (STISIM Drive-Recorded Variable) Recorded by the STISIM simulator during the simulation @2.5 hours
Secondary Mean and Standard Deviation of Acceleration in Meters/Second (STISIM Drive-Recorded Variable) Recorded by the STISIM simulator during the simulation @2.5 hours
Secondary Blood Pressure (Systolic/Diastolic mmHg) Systolic & diastolic blood pressure via automated blood pressure cuff @25 minutes and 2 hours
Secondary Heart Rate (BPM) & Heart Rate Variability via ECG Continuous heart rate in beats per minute via 3-lead electrocardiography recording; will allow for calculation of heart rate variability) Hour 0-3.5
Secondary Electrical Brain Activity via EEG Continuous brain activity via electroencephalography recording Hour 0-3.5
Secondary Median Response Time and Efficiency in Alerting, Orienting & Executive Attention as Measured by the Attention Network Test (in milliseconds) A computerized test to measure participants' performance in three separate components of attention: alerting, orienting, and executive attention @25 minutes and 2 hours
Secondary Perceptual Motor Speed & Efficiency as Measured by Time (in seconds) to Complete Trail Making Tests A&B A pen and paper test to measure perceptual motor speed and efficiency @25 minutes and 2 hours
Secondary Visual Analogue Scale of Perceived Effects Ratings of participants' current perceptions of mood and bodily sensations (22 items including anxiety, alertness, dizziness, dry mouth) driving (3 items related to current willingness to drive), and subjective impairment (at time 2 only; 6 items related to strength of effects, perceived performance on tests); all items measures from not at all>extremely or absent>severe on a 100 mm line @25 minutes and 2 hours
See also
  Status Clinical Trial Phase
Recruiting NCT05414344 - A Brief Intervention for Alcohol Users With Interpersonal Trauma N/A
Completed NCT05521906 - Evaluation of PRYSHM for LGBTQIA2S+ Youth N/A
Not yet recruiting NCT04786587 - Alcohol Self-reporting During Pregnancy. AUTOQUEST Study.
Withdrawn NCT04659278 - Endourage Complete Spectrum Oral Mucosal Drops (OMD) in Adults Desiring a Reduction in Ethanol Use N/A
Not yet recruiting NCT03632408 - Hangover and Residual Zopiclone Effect on Spatial Perception Phase 1
Completed NCT02718508 - An e-Parenting Skills Intervention to Decrease Injured Adolescents' Alcohol Use N/A
Active, not recruiting NCT02629679 - Sports, Education and Consumption of Substances in Adolescents N/A
Completed NCT02945371 - Tailored Inhibitory Control Training to Reverse EA-linked Deficits in Mid-life N/A
Completed NCT01553136 - Varenicline Treatment of Alcohol Dependence in Smokers Phase 2
Completed NCT01442753 - Family-Skills Training to Prevent Tobacco and Other Substance Use in Latino Youth N/A
Completed NCT01081119 - Brief Voluntary Alcohol and Drug Intervention for Middle School Youth Phase 2
Completed NCT00289965 - Substance Use Risk Education (SURE) Project Phase 2
Completed NCT04510116 - Adults In The Making Prevention Trial N/A
Completed NCT00506753 - Motivation and Skills for Delta-9-tetrahydrocannabinol/Ethanol (THC/ETOH+) Teens in Jail N/A
Recruiting NCT05288790 - Microbiome Metabolites and Alcohol in HIV to Reduce CVD RCT Phase 2
Recruiting NCT05620849 - Young Adult Education on Alcohol & Health N/A
Recruiting NCT03588754 - Does Propranolol, a Beta Blocker, Attenuate Stress-Induced Drinking? Phase 2
Recruiting NCT04054466 - Nursing Counseling to the Change of Behavior of Alcohol Consumption in Patients in HAART N/A
Recruiting NCT06074341 - TeleHealth Resources for IndiVidualizEd Goals (THRIVE) in Alcohol Recovery Study N/A
Terminated NCT04596267 - Pitolisant Effects on Alcohol Self-Administration in Heavy Drinkers Phase 1